Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
JM Gaspoz, P de Moerloose - The American journal of medicine, 2004 - amjmed.com
According to the World Health Organization, car-diovascular diseases caused 16.6 million
deaths worldwide (29.3% of all deaths) in 2001. Coronary heart disease was the leading …
deaths worldwide (29.3% of all deaths) in 2001. Coronary heart disease was the leading …
[引用][C] Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
JM Gaspoz, P de Moerloose - The American Journal of Medicine, 2004 - europepmc.org
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
[引用][C] Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
JM Gaspoz, P de Moerloose - The American Journal of Medicine, 2004 - infona.pl
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner? ×
Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's …
Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's …
[引用][C] Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
JM Gaspoz, P de Moerloose - The American journal of …, 2004 - pubmed.ncbi.nlm.nih.gov